NETANYA, Israel, February 8, 2017 /PRNewswire/ --
Intensix, developer of a real-time predictive analytics platform for early detection of patient deterioration in the ICU and high acuity departments of hospitals, announced today that it has completed an $8.3 million Series A financing round led by Pitango Venture Capital. The funds will be used to boost the company's sales and marketing operations in North America and to expand and accelerate the development of its predictive analytics platform.
Intensix also announced today that as part of the financing Ittai Harel, Managing General Partner at Pitango, will join the company's Board of Directors.
Intensix's pioneering platform applies machine learning to provide accurate predictive clinical analytics that ICU and high-acuity staff and management can use to avoid deteriorations, save lives as well as secure operational and financial benefits. Studies to date show that the Intensix solution has the potential to significantly improve clinical outcomes and reduce the average length of hospital stay, thereby lowering hospital treatment costs and increasing the possibility of new revenue sources.
Intensix CEO Gal Salomon said, "Predictive modelling coupled with machine learning, represents a paradigm shift in the delivery of high-acuity healthcare. Following several successful studies, we are pleased to have secured backing by high quality investors. This support will enable the company to expand and advance the capabilities of our platform and accelerate deployment in the US and EU."
Mr. Harel said, "The explosion of patient data, via electronic health records, sensors, and medical devices, provides physicians with an untapped wealth of new information. Machine learning and predictive analytics have the power to harness this data, offering great value to the healthcare industry, particularly in the area of critical care. In successive studies, Intensix has consistently demonstrated its ability to predict life-threatening deterioration and we are pleased to back them as they work to substantially improve patient outcomes"
Intensix provides healthcare providers and administrators with high-accuracy predictive analytics that improve clinical outcomes and reduce hospital costs. The Intensix innovative analytics solution detects deterioration in real-time and delivers predictive warnings during all phases of a patient's stay in the ICU and other high-acuity departments. Driven by innovative predictive modelling and advanced high-dimensional analytics techniques, the Intensix platform has the flexibility to manage entire patient populations as well as individualized treatment needs.
About Pitango Venture Capital
Pitango has been investing in technology ventures since 1993 and now has more than $2 billion under management. Pitango invests in Israeli tech and health care companies, in various fields and all stages. Pitango Venture Capital has invested in over 200 companies, many of which have become public or were acquired by strategic players.
Learn more at: pitango.com
*Products and trade names mentioned herein are the trademarks of their respective owners.